Literature DB >> 3143077

Antigen presenting function of class II MHC expressing pancreatic beta cells.

J Markmann1, D Lo, A Naji, R D Palmiter, R L Brinster, E Heber-Katz.   

Abstract

Class II major histocompatibility complex (MHC) gene expression in the mouse is generally limited to thymic epithelium and bone marrow-derived cells such as B lymphocytes and cells of the macrophage/dendritic cell lineage (M phi/DC). Class II-bearing B lymphocytes and M phi/DC possess antigen presenting cell (APC) function; that is, they can stimulate T lymphocytes reactive to either antigen plus MHC or foreign MHC alone. To assess whether non-bone-marrow-derived cells can acquire APC function and elicit graft rejection through expression of class II, we studied transgenic pancreatic islet beta cells that express a foreign class II (I-E) molecule. In vivo, grafts of I-E+ transgenic islets into I-E- naive hosts are not rejected unless the host is primed by an injection of I-E+ spleen cells. In vitro, the I-E+ beta cells are unable to stimulate T lymphocytes reactive to I-E plus a peptide antigen. Paradoxically, they induce antigen specific unresponsiveness in the T cells. We propose that expression of class II on non-lymphoid cells may serve as an extrathymic mechanism for maintaining self tolerance.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3143077     DOI: 10.1038/336476a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  44 in total

Review 1.  Immune regulation: susceptibility and resistance to autoimmunity.

Authors:  D Lo
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

2.  Immunohistology of oral lesions from patients with recurrent oral ulcers and Behçet's syndrome.

Authors:  L W Poulter; T Lehner
Journal:  Clin Exp Immunol       Date:  1989-11       Impact factor: 4.330

Review 3.  Non-obese diabetic transgenic mouse.

Authors:  K Yamamura; T Miyazaki; M Uno; T Toyonaga; J Miyazaki
Journal:  Springer Semin Immunopathol       Date:  1992

4.  Difference between bacterial and food antigens in mucosal immunogenicity.

Authors:  A E Wold; U I Dahlgren; L A Hanson; I Mattsby-Baltzer; T Midvetdt
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

Review 5.  Control of self-reactivity in the intestine.

Authors:  T A Barrett; S M Hedrick; A L Dent; M L Delvy; D M Kennedy; L A Matis; J A Bluestone
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

Review 6.  Analysis of antigen presentation using HLA transfectants.

Authors:  D M Altmann; D Wilkinson; H Ikeda; J Trowsdale
Journal:  Immunol Res       Date:  1990       Impact factor: 2.829

Review 7.  I-E transgenic mice: a model system to dissect the regulation and function of MHC class II genes in vivo.

Authors:  L C Burkly; D Lo; R L Brinster; R A Flavell
Journal:  Immunol Res       Date:  1990       Impact factor: 2.829

8.  Peripheral tolerance to allogeneic class II histocompatibility antigens expressed in transgenic mice: evidence against a clonal-deletion mechanism.

Authors:  K M Murphy; C T Weaver; M Elish; P M Allen; D Y Loh
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

9.  Xenotransplantation of pancreatic and kidney primordia-where do we stand?

Authors:  Marc R Hammerman
Journal:  Transpl Immunol       Date:  2008-11-06       Impact factor: 1.708

10.  Treating activated CD4+ T cells with either of two distinct DNA methyltransferase inhibitors, 5-azacytidine or procainamide, is sufficient to cause a lupus-like disease in syngeneic mice.

Authors:  J Quddus; K J Johnson; J Gavalchin; E P Amento; C E Chrisp; R L Yung; B C Richardson
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.